Üveitlere Romatolojik Yaklaşım

Year 2019, Volume: 2 Issue: 3, 150 - 159, 20.12.2019

Sertaç Ketenci Ender Salbaş

https://doi.org/10.33713/egetbd.644034

Abstract

Özet: Üveit terimi gözün kanlanmasını sağlayan katmanların inflamasyonunu ifade eder. Altta yatan neden idiyopatik olabileceği gibi, enfeksiyonların, romatolojik hastalıkların, ilaç yan etkilerinin bir yansıması olarak da karşımıza çıkabilir. Etiyolojisinde sistemik inflamatuvar patolojilerin yoğun olarak yer alması nedeniyle üveit tanılı hastaları oftalmologlar dışında en sık gören hekimler romatologlardır. Tanı, tedavi ve takip açısından en sık kullanılan sınıflandırma olan anatomik sınıflandırmada üveitler ön, orta, arka ve pan üveit olarak 4 ana grupta ele alınır. Ön üveitler, tüm üveitlerin %80’ini oluşturur. Sebepleri olarak ön planda idiyopatik üveitler, spondiloartropatiler (SpA), herpetik virüsler ve Behçet hastalığı sayılabilir. Akut ön üveitli (AAU) hastalar kliniğe kızarık göz, fotofobi ve ağrı ile başvurur. Tipik olarak tek gözde inflamasyon görülür. Nadiren iki taraflı ataklar da saptanabilir. Kronik ön üveite Romatoloji pratiğinde AAU’ya göre daha nadir rastlanılmakla beraber, en sık ilişkili olduğu durum Jüvenil İdiyopatik Artrittir (JİA). Orta Üveite (IU) neden olan en sık iki etken Multipl Skleroz (MS) ve Sarkoidozdur. Diğer hastalıklar Sifiliz, Toksoplazma, Toksokara, Tüberküloz, EBV enfeksiyonları şeklinde sıralanabilir. Ön üveitlerde beklenen kırmızı göz, ağrı gibi semptom ve bulgular arka üveitlerde beklenmez. Ülkemizde arka üveit tanılı hastaların %40’tan fazlasında Behçet Hastalığı bildirilmekteyken,  Avrupa verilerinde idiyopatik üveitler, enfeksiyonlar ve Sarkoidoz gibi sebepler ön planda gözlenmektedir. Ülkemizde yapılan çalışmalarda panüveit sıklığı %26,7 ile ön üveitten sonraki ikinci en sık üveit grubunu oluşturur. Behçet Hastalığı ve idiyopatik panüveit önde gelen iki sebebi oluşturmaktadır. Bu derleme ile üveitlerin romatoloji penceresinden kapsamlı olarak ele alınması amaçlanmıştır.


 


Abstract: The term uveitis refers to inflammation of the layers that provide blood to the eye. The underlying cause may be idiopathic or reflection of infections, rheumatologic diseases and as a drug side effect. Due to the involvement of systemic inflammatory pathologies in the etiology; Rheumatologists are the most common physicians who see uveitis patients except ophthalmologists. According to anatomical structure, uveitis is classified into 4 main groups as anterior, middle, posterior and pan uveitis. This grouping; is the most commonly used classification in terms of diagnosis, treatment and follow - up. Anterior uveitis accounts for 80% of all uveitis. The causes of anterior uveitis include idiopathic uveitis, spondyloarthropathies (SpA), herpetic viruses and Behçet's disease. Patients with acute anterior uveitis (AAU) have complaints of red-eye, photophobia and pain. Inflammation is typically seen in one eye. Rarely, bilateral attacks can also be found. Chronic anterior uveitis is less common in rheumatology practice than AAU, but it’s most common association is Juvenile Idiopathic Arthritis (JIA). The two most common causes of intermediate uveitis (IU) are Multiple Sclerosis (MS) and Sarcoidosis. Other diseases include Syphilis, Toxoplasma, Toxocara, Tuberculosis, EBV infections. Symptoms and signs such as red eye and eye pain that expected in anterior uveitis are not expected in posterior uveitis. Behçet's disease has been reported in more than 40% of the patients with posterior uveitis in Turkey, while European data shows that idiopathic uveitis, infections and sarcoidosis are the main causes for posterior uveitis. In Turkey, the prevalence of panuveitis is 26.7% and it is the second most common uveitis group after anterior uveitis. Behçet's disease and idiopathic panuveitis are two leading causes. The aim of this review is to investigate the uveitis from rheumatology window comprehensively.

Keywords

romatoloji, üveit

References

• KAYNAKLAR1) Şengün A. Sınıflandırma. In:Akbatur H(ed). Behçet Hastalığı Endoftalmiler ve Üveitler. Ankara: AtlasYayıncılık;2002:27-322) Thorne JE, Suhler E, Skup M, et al. Prevalence of Noninfectious Uveitis in the United States: A Claims-Based Analysis. JAMA Ophthalmol. 2016;134(11):1237–12453) Rosenbaum, J. T. Uveitis: etiology, clinical manifestations, and diagnosis. UpToDate [Cited 24.10.2019] Avaible from: https://www.uptodate.com/contents/uveitis-etiology-clinical-manifestations-and-diagnosis4) Pivetti-Pezzi P, Accorinti M,La Cava M et al: Endogeneous uveitis: an analysis of 1417 cases. Ophthalmologica 1996;210:234-85) Özdal M , Yazıcı A , Tüfek M et al . Epidemiology of uveitis in a referral hospital in Turkey. Turkish Journal of Medical Sciences. 2014; 44(2): 337-3426) Rodriguez A, Calonge M, Pedroza-Seres M et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996;114(5):593-97) Hosseini SM , Shoeibi N , Ebrahimi R et al.Patterns of Uveitis at a Tertiary Referral Center in Northeastern Iran. J Ophthalmic Vis Res 2018; 13 (2): 138–143 8) Rathinam SR, Babu M. Algorithmic approach in the diagnosis of uveitis. Indian J Ophthalmol. 2013;61(6):255–2629) Jabs DA, Nussenblatt RB, Rosenbaum JT et al. Standardization of uveitis nomenclature for repoating clinical data. Results of the first international workshop. Am J Ophthalmol 2005;140(3):509-1610) Haluk Kazokoglu, Sumru Onal, Ilknur Tugal-Tutkun et al. Demographic andClinical Features of Uveitis in Tertiary Centers in Turkey, Ophthalmic Epidemiology, 2008;15(5): 285-29311) Chan S, Gan K, Weis E. (2010). Characteristics and predictors of recurrence of anterior and intermediate uveitis in a Canadian referral centre. Can J Ophthalmol.2010;45: 144-8.12) Otasevic L, Zlatanovic G, Stanojevic-Paovic A et al. Helicobacter pylori: An Underestimated Factor in Acute Anterior Uveitis and Spondyloarthropathies? Ophthalmologica 2007;221:6-13.13) Khan IR, Thorne JE, Jabs DA. The eyes in rheumatic disease. In Hochberg M (ed) Rheumatology 7th ed , Philadelphia, Elsevier 2019:279-85.14) Zaidi AA, Ying GS, Daniel E, et al. Hypopyon in patients with uveitis. Ophthalmology. 2010;117(2):366–372.15) Hansen BA, Soukiasian SH. Approach to the Laboratory,Imaging and Molecular work-up for uveitis , In: Papaliodis GN (ed) , Uveitis, Switzerland , Springer 2017 : 9-3416) Bhagat N, Read RW, Rao NA et al. Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immuncompetent individuals. Ophthalmol. 2001;108(4):750-217) McCluskey PJ, Towler HM, Lightman S. Management of chronic uveitis. BMJ. 2000;26;320(7234):555-818) Akbatur H. Orta Üveitler . In:Akbatur H(ed). Behçet Hastalığı Endoftalmiler ve Üveitler. Ankara: AtlasYayıncılık;2002:131-3819) Janigian RH. Intermediate Uveitis: Medscape [Cited 24.10.2019] Avaible from: https://emedicine.medscape.com/article/1208794-overview20) Grillo A, Levinson RD, Gordon LK. Practical diagnostic approach to uveitis. Expert Review of Ophthalmology, 2011; 6(4), 449–459. 21) Kaya D, Kaya M, Özakbaş S, İdiman E. Uveitis associated with multiple sclerosis: complications and visual prognosis. Int J Ophthalmol. 2014;7(6):1010–1013. 22) Burkholder BM, and James PD. "Multiple sclerosis-associated uveitis." Expert Review of Ophthalmology, 2012: 7(6): 587.23) Babu BM, Rathinam SR. Intermediate uveitis. Indian J Ophthalmol. 2010;58(1):21–27.24) Yalçındağ FN, Özdal PC, Özyazgan Y et al. Demographic and Clinical Characteristics of Uveitis in Turkey: The First National Registry Report. Ocular Immunology and Inflammation, 2018;26(1): 17-2625) Hautala, N, Siiskonen, M. , Salmi, J. and Hautala, T., Aetiology of posterior uveitis in a tertiary centre in Finland. Acta Ophthalmol. 2019 doi:10.1111/aos.1418226) Akbatur H. Arka Üveitler . In:Akbatur H(ed). Behçet Hastalığı Endoftalmiler ve Üveitler. Ankara: AtlasYayıncılık;2002:151-5827) Abu El-Asrar Ahmed M, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitidis. Middle East Afr J Ophthalmol. 2009 ; 16(4): 202–1828) Akbatur H. Arka Üveitler . In:Akbatur H(ed). Behçet Hastalığı Endoftalmiler ve Üveitler. Ankara: AtlasYayıncılık;2002:335-4329) Bashaour M. Ophthalmologic manifestations of Behcet Disase Medscape [Cited 24.10.2019] Avaible from: https://emedicine.medscape.com/article/1229174-overview#a6 30) Hazirolan D, Sungur G, Duman S. Demographic,clinical and ocular features in patients with late-onset Behcet Disase. Ocular Immunol Inflamm. 2012; 20(2): 119-2431) Kaçmaz RO, Kempen JH, Newcomb J et al. Systemic Immunssupressive Therapy for Eye Disases Cohort Study Group. Ocular Inflammation in Behçet Disase: incidence of ocular complications and loss of visual acuity. Am J Ophthalmol . 2008;146:828-836.32) Thorne JE, Jab DA. Rheumatic disases. In: Ryan SJ, ed. The retina 6th ed. London: Elsevier;2012:1383-140833) Khairallah M, Accorinti M, Muccioli C et al. Epidemiology of Behcet disase. Ocular Immunol Inflamm. 2012;20(5):324-3534) Lorch A, Sobrin L. Adamantiades-Behçet’s Disase. In: Papaliodis GN (ed) , Uveitis, Switzerland , Springer 2017 : 121-2735) Sahli E , Koz ÖG. Ocular Manifestations of Behçet’s Disase. IntechOpen [Cited 24.10.2019] Available from: https://www.intechopen.com/books/behcet-s-disease/ocular-manifestations-of-beh-et-s-disease36) Tugal IT, Onal S, Ozyazgan Y et al. Validity and Agreement of Uveitis Experts in Interpretation of Ocular Photographs for Diagnosis of Behçet Uveitis, Ocular Immunology and Inflammation 2014; 22(6) : 461-837) Zamecki KJ, Jabs AD. HLA typing in uveitis: use and misuse. Am J Ophthalmol. 2010 ;149(2):189-193.38) Brewerton DA, Caffrey M, Nicholls A, et al. Acute Anterior Uveitisi and HLA-B27 Lancet. 1973:994-639) Letko E.HLA-B27. In: Papaliodis GN (ed) , Uveitis, Switzerland , Springer 2017 : 171-7640) Sharma SM, Jackson D , Uveitis in the Spondyloarthopathies Best Practice & Research Clinical Rheumatology (2017);31: 846-86241) de la Maza DS . Seronegative Spondyloarthropaties In :Foster CS (ed) Diagnosis and treatment of Uveitis, Philadelphia WB Saunders Company :581-601.42) Dacey M. Ankylosing Spondylitis. In: Papaliodis GN (ed) , Uveitis, Switzerland , Springer 2017 : 135-41.43)Ghanchi FD,Rembacken BJ. Inflammatory bowel disase and the eye. Surv Ophthalmol. 2003;48(6): 663-7644)Felekis T, Katsonos K, Kitsanou M et al. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disase: a prospective single center study. Inflamm Bowel Dis. 2009;15(1): 29-3445 ) Borkar DS, Butler NJ. Inflammatory bowel disase. In: Papaliodis GN (ed) , Uveitis, Switzerland , Springer 2017 : 177-82.46) SalmonJF, Wright Jp, Murray AD . Ocular inflammation in Chron ‘s Disase . Opthalmology. 1991; 98 (4): 480-447)Lyons JL, Rosenbaum JT. .Uveitis associated with inflammatory bowel disase compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 1997;115(1):61-448) Kammer GM, Soter NA, Gibson DJ et al Psoriatic arthritis: a clinical, immunologic and HLA Study of 100 patients. Semin Arthritis Rheum. 1979;9(2):75-9749) Hunter R. Psoriasis Associated. In: Papaliodis GN (ed) , Uveitis, Switzerland , Springer 2017 : 221-2950) Butbul YA, Tyrrell PN, Schneider R et al. Comparision of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they? J Rheumatol. 2009; 36(9):2033-41.51) Heiligenhaus A, et al.Prevelance and complications of uveitis in juvenile idiopathic arthritis in a population-based nation wide study in Germany: suggested modification of current screening guidelines. Rheumatology (oxford) 2007;46 (6):1015-952) Angeles-Han ST, McCracken C, Yeh S, et al. Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis. Pediatr Rheumatol Online J. 2015;13:19. 53) Sen ES, Ramanan AV. Juvenile İdiopathic Arthritis –associated uveitis Best Practice & Research Clinical Rheumatology 2017;31: 517-53454) Lobo AM. Juvenile İdiopathic Arthritis. In: Papaliodis GN (ed) , Uveitis, Switzerland , Springer 2017 :183-855) Angeles-Han ST, Ringold S, Beukelman T et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis . Arthritis Care Res (Hoboken). 2019 Jun;71(6):703-71656)Blaise P, Ferdeau C, Chapelon C et al. Minor salivary gland biopsy in diagnosing ocular sarcoidosis. Br J Ophthalmol. 2011;95(12):1731-457)Rıthıva A, Alberts C, Glasius E et al. Risk factors for ocular sarcoidosis. Doc Ophthalmol. 1989;72(3-4):287-9658)Jones NP. The Manchester uveitis clinic: the first 3000 patients-epidemiology and casemix. Ocul Immunol Inflamm. 2015;23(2):118-2659) Pepple KL, Van Gelder RN. Sarcoidosis. In: Papaliodis GN (ed) , Uveitis, Switzerland , Springer 2017 :243-5260) Akbatur H. Sarkoidozis. In:Akbatur H(ed). Behçet Hastalığı Endoftalmiler ve Üveitler. Ankara: AtlasYayıncılık;2002:177-9061)Dana MR, Merayo-Lioves J, Schaumberg DA et al. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1996;103:1846-5362)Rahmani S. Uveitis in GPA: In: Papaliodis GN (ed) , Uveitis, Switzerland , Springer 2017 :291-9363)Rothschild PR, Pagnoux C, Seror R et al. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literatura. Semin Arthritis Rheum. 2013;42(5):507-1464) Watkins As, Kempen JH, Choi D et al. Ocular disase in patients with ANCA-positive vasculitidis. J Ocul Biol Dis Infor. 2012;3(1):12-965) Kubaisi B, Abu Samra K, Foster CS. Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. Intractable Rare Dis Res. 2016;5(2):61–69.66) Ungprasert P, Crowson CS, Cartin-Ceba R, et al. Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study. Rheumatology (Oxford). 2017;56(10):1763–177067) Soukiasian SH .Wegener’s Granulomatosis In :Foster CS (ed) Diagnosis and treatment of Uveitis, Philadelphia WB Saunders Company :661-675